ClinicalTrials.Veeva

Menu

An Intervention to Reduce Sedentary Behavior for Black Adults With Chronic Kidney Disease (RESET-CKD)

University of Illinois logo

University of Illinois

Status

Enrolling

Conditions

Chronic Kidney Disease(CKD)

Treatments

Other: Attention Control
Behavioral: RESET-CKD

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06754280
K23NR021034 (U.S. NIH Grant/Contract)
2024-1410

Details and patient eligibility

About

RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.

Enrollment

40 estimated patients

Sex

All

Ages

35 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Self-identifies as Black or African American
  • Age ≥35 to ≤80 years old
  • CKD Stage 1-4
  • Self-reported 6 or more hours/day of sedentary time
  • Ability to speak/read/understand English
  • Has access to a telephone

Exclusion criteria

  • Being unable to walk 1 block
  • Being unable to stand from a seated position without assistance
  • Using a wheelchair, walker, or cane for all of their ambulation
  • Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension
  • Kidney transplant
  • Any other condition that the investigator considers precludes participation in the trial
  • Participated in the Patient Advisory Board

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

RESET-CKD
Experimental group
Description:
RESET-CKD is a 12-week intervention that consists of four major components to support decreasing sedentary behavior: (1) health coaching, (2) feedback charts on sedentary behavior, (3) a workbook, and (4) reminders and cues.
Treatment:
Behavioral: RESET-CKD
Attention Control
Active Comparator group
Description:
CKD-related education
Treatment:
Other: Attention Control

Trial contacts and locations

1

Loading...

Central trial contact

Mary Hannan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems